• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Accent Microcell Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 92465.0
  • ISIN : INE0Q5D01013
277.70 -1 (-0.27%)
  • As on 12 Jul 2025 (EOD)

  • Today’s Low

    271.60

  • Today’s High

    288.00

  • Open

    277.55

  • Perv Close

    278.45

  • 52W Low

    170.26

  • 52W High

    292.00

Key Indicators

  • P/E(TTM)

    20.15

  • Mar.Cap (₹Cr.)

    666.18

  • Div & Yield %

    0.36

  • Book Value(₹)

    97.78

  • Debt-Equity Ratio

    -0.27

  • AGM Date

    11-Jul-2025

  • EPS

    13.78

  • P/E Ratio

    20.15

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    666.18

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.99

  • BV (₹)

    97.80

  • Sales( ₹ in Cr.)

    264.58

  • NP (in Cr.)

    33.06

  • NP Var(%)

    7.0

  • Div%

    0.0

  • CPS (₹)

    15.50

  • EPS (₹)

    13.80

  • Traded Value (₹ in Lakhs)

    666.18

  • 52 Week High

    292.00

  • 52 Week Low

    170.26

  • Price BSE

    0.0

  • Price NSE

    278.00

  • Market Capital( in Cr.)

    666.18

  • P/C Ratio

    17.90

  • P/E Ratio

    20.20

  • Price Vs.BV

    13.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 245.50 197.27 165.71 132.57 131.38 113.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 245.50 197.27 165.71 132.57 131.38 113.99
Other Income 3.63 2.49 1.83 2.25 3.99 5.54
Stock Adjustments -14.62 9.71 6.94 8.94 3.61 0.22
Total Income 234.51 209.47 174.48 143.76 138.98 119.75
EXPENDITURE :            
Raw Materials 131.31 129.19 120.28 99.05 88.69 76.06
Power and Fuel Cost 22.71 23.26 3.34 3.16 4.87 4.37
Employee Cost 11.03 8.97 7.62 6.93 9.42 7.53
Other Manufacturing Expenses 11.26 9.63 9.94 9.85 10.49 10.74
Selling and Administration Expenses 12.83 16.54 17.51 10.65 12.53 9.65
Miscellaneous Expenses 3.27 0.45 0.98 1.18 0.20 0.22
Employee Benefit Expenses 11.03 8.97 7.62 6.93 9.42 7.53
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 192.40 188.03 159.67 130.82 126.21 108.58
Operating Profit 42.11 21.44 14.81 12.94 12.77 11.17
Interest 1.15 2.53 3.07 3.38 3.41 3.17
Gross Profit 40.96 18.91 11.74 9.56 9.36 8.00
Depreciation 4.43 4.11 4.15 3.55 3.30 3.24
Profit Before Tax 36.53 14.80 7.59 6.01 6.06 4.76
Current Tax 6.39 2.59 1.66 1.19 1.01 1.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.03 -0.02 0.04 0.01 0.87 0.13
Reported Net Profit 30.17 12.23 5.89 4.80 4.18 3.62
Extraordinary Items -0.83 0.00 0.00 -0.22 0.00 0.00
Adjusted Net Profit 31.00 12.23 5.89 5.02 4.18 3.62
Adjustment below Net Profit 0.00 0.00 0.00 -3.27 0.00 0.00
P & L Balance brought forward 36.62 24.38 12.95 11.42 7.24 3.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.04 0.00 0.43 0.00 0.00 0.00
P & L Balance carried down 65.75 36.62 18.41 12.95 11.42 7.24
Dividend 1.04 0.00 0.43 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 8.00 8.00 10.00 0.00 0.00
Dividend Per Share(Rs) 1.00 0.80 0.80 1.00 0.00 0.00
Earnings Per Share-Unit Curr 14.34 9.45 4.57 11.17 9.71 8.42
Earnings Per Share(Adj)-Unit Curr 13.56 - - - - -
Book Value 77.86 38.96 24.87 61.92 58.36 48.64
Book Value(Adj)-Unit Curr 73.65 - - - - -

Shareholding Pattern

  • Promoter Group

    55.09%

  • Public Share Holding

    44.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,593,500 55.09 11,593,500 16
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,593,500 55.09 11,593,500 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,500 0.01 2,500 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 461,000 2.19 461,000 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 463,500 2.20 463,500 5
2] Non Institution
Bodies Corporate 387,000 1.84 387,000 60
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 152,500 0.72 152,500 85
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 554,000 2.63 554,000 173
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,463,500 21.21 4,463,500 52
Individuals holding nominal share capital up to Rs. 1 lakh 3,425,500 16.28 3,425,500 2,441
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,500 0.02 3,500 2
Others 0 0.00 0 0
Sub Total 8,986,000 42.70 8,986,000 2,813
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,043,000 100.00 21,043,000 2,834

Company Background

Accent Microcell LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Accent Microcell Ltd
  • BSE Code : 92465.0
  • ISIN : INE0Q5D01013

  • Incorporation Year

    2012

  • Registered Office

    314 Shangrilla Arcade Shyamal-
    Crs.Rd Anandnagar Rd Satellite, Ahmedabad,
    Gujarat-380015

  • Telephone

    +91 75758 03351

  • FAX

  • Chairman

    Vasant Vadilal Patel

  • Managing Director

    Ghanshyam Arjanbhai Patel

  • Company Secretary

  • Auditor

    T R Chadha & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Accent Microcell Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Accent Microcell 277.70 249.13 245.50 20.15 30.04
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10